Aug 2026
METTL14-mediated m6A modification of CCNE1 accelerates progression of myelodysplastic syndromes via MAPK-ERK and PI3K-AKT signaling pathways.
A METTL14/m6A/CCNE1 signaling axis in MDS progression is delineated and suggests that METTL14-mediated m6A modification may be a potential therapeutic target for MDS.
Xiao-Lin Liang, Jiamin Luo, Yiqian Huang et al.
· Cellular Signalling · 0 citations